Mark A. Bryniarski

521 total citations
14 papers, 411 citations indexed

About

Mark A. Bryniarski is a scholar working on Molecular Biology, Nephrology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark A. Bryniarski has authored 14 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Nephrology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark A. Bryniarski's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Diet and metabolism studies (3 papers) and Gut microbiota and health (3 papers). Mark A. Bryniarski is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Diet and metabolism studies (3 papers) and Gut microbiota and health (3 papers). Mark A. Bryniarski collaborates with scholars based in United States, Ireland and Panama. Mark A. Bryniarski's co-authors include Rabi Yacoub, Marilyn E. Morris, Lee Chaves, Xiaowen Guan, Richard J. Quigg, Ji Li, D. Paul Thomas, Jun Wang, Su Qian and Alex Morrison and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Mark A. Bryniarski

14 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Bryniarski United States 10 188 94 76 66 59 14 411
You Na China 6 175 0.9× 62 0.7× 50 0.7× 37 0.6× 66 1.1× 8 364
Yiqiong Ma China 14 276 1.5× 54 0.6× 199 2.6× 69 1.0× 63 1.1× 19 596
Nadezda V. Andrianova Russia 13 232 1.2× 98 1.0× 85 1.1× 54 0.8× 12 0.2× 43 482
Xueyan Yang China 10 169 0.9× 27 0.3× 131 1.7× 41 0.6× 40 0.7× 18 380
Minglin Pan China 9 237 1.3× 93 1.0× 28 0.4× 17 0.3× 28 0.5× 13 426
Shilu Luo China 13 307 1.6× 99 1.1× 88 1.2× 49 0.7× 9 0.2× 36 620
Vanessa Marchant Spain 12 244 1.3× 52 0.6× 176 2.3× 38 0.6× 10 0.2× 25 658
Wei Xing China 11 191 1.0× 27 0.3× 22 0.3× 24 0.4× 22 0.4× 38 428
Maohua Pei China 11 262 1.4× 60 0.6× 50 0.7× 31 0.5× 6 0.1× 14 431
Jun Honjo Japan 12 240 1.3× 81 0.9× 115 1.5× 41 0.6× 12 0.2× 19 634

Countries citing papers authored by Mark A. Bryniarski

Since Specialization
Citations

This map shows the geographic impact of Mark A. Bryniarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Bryniarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Bryniarski more than expected).

Fields of papers citing papers by Mark A. Bryniarski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Bryniarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Bryniarski. The network helps show where Mark A. Bryniarski may publish in the future.

Co-authorship network of co-authors of Mark A. Bryniarski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Bryniarski. A scholar is included among the top collaborators of Mark A. Bryniarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Bryniarski. Mark A. Bryniarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bryniarski, Mark A., Timothy M. Acker, Devin L. Wakefield, et al.. (2024). Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal Antibodies. Journal of Pharmaceutical Sciences. 113(9). 2879–2894. 2 indexed citations
2.
Bryniarski, Mark A., Fatemeh Nasrollahi, Eunkyung Ko, et al.. (2024). Utility of Cellular Measurements of Non-Specific Endocytosis to Assess the Target-Independent Clearance of Monoclonal Antibodies. Journal of Pharmaceutical Sciences. 113(10). 3100–3111. 2 indexed citations
3.
Bryniarski, Mark A., Ruben M. Sandoval, Rabi Yacoub, et al.. (2023). Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular Pharmaceutics. 20(2). 987–996. 2 indexed citations
4.
Chaves, Lee, Mark A. Bryniarski, Daniel McSkimming, et al.. (2021). Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake. JCI Insight. 6(11). 12 indexed citations
5.
Bryniarski, Mark A., Lee Chaves, Jakob Hauge Mikkelsen, et al.. (2021). Immunoglobulin G Is a Novel Substrate for the Endocytic Protein Megalin. The AAPS Journal. 23(2). 40–40. 9 indexed citations
6.
Bryniarski, Mark A., et al.. (2020). Megalin-mediated albumin endocytosis in cultured murine mesangial cells. Biochemical and Biophysical Research Communications. 529(3). 740–746. 11 indexed citations
7.
Bryniarski, Mark A., et al.. (2020). Targeting the Choroid Plexuses for Protein Drug Delivery. Pharmaceutics. 12(10). 963–963. 19 indexed citations
8.
Bryniarski, Mark A., et al.. (2019). The role of chronic kidney disease-associated dysbiosis in cardiovascular disease. Experimental Biology and Medicine. 244(6). 514–525. 15 indexed citations
9.
Yacoub, Rabi, Girish N. Nadkarni, Daniel McSkimming, et al.. (2018). Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study. Experimental Biology and Medicine. 244(6). 505–513. 16 indexed citations
10.
Guan, Xiaowen, Mark A. Bryniarski, & Marilyn E. Morris. (2018). In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model. The AAPS Journal. 21(1). 3–3. 40 indexed citations
11.
Chaves, Lee, Daniel McSkimming, Mark A. Bryniarski, et al.. (2018). Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. American Journal of Physiology-Renal Physiology. 315(3). F487–F502. 42 indexed citations
12.
Bryniarski, Mark A., et al.. (2018). Increased megalin expression in early type 2 diabetes: role of insulin-signaling pathways. American Journal of Physiology-Renal Physiology. 315(5). F1191–F1207. 25 indexed citations
13.
Yacoub, Rabi, Girish N. Nadkarni, Lee Chaves, et al.. (2017). Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS ONE. 12(9). e0184789–e0184789. 113 indexed citations
14.
Tong, Chao, Alex Morrison, Su Qian, et al.. (2012). Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress. The FASEB Journal. 27(11). 4332–4342. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026